Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Malar J. 2020 Jul 27;19(1):271. doi: 10.1186/s12936-020-03330-5.
The Asia-Pacific region faces formidable challenges in achieving malaria elimination by the proposed target in 2030. Molecular surveillance of Plasmodium parasites can provide important information on malaria transmission and adaptation, which can inform national malaria control programmes (NMCPs) in decision-making processes. In November 2019 a parasite genotyping workshop was held in Jakarta, Indonesia, to review molecular approaches for parasite surveillance and explore ways in which these tools can be integrated into public health systems and inform policy. The meeting was attended by 70 participants from 8 malaria-endemic countries and partners of the Asia Pacific Malaria Elimination Network. The participants acknowledged the utility of multiple use cases for parasite genotyping including: quantifying the prevalence of drug resistant parasites, predicting risks of treatment failure, identifying major routes and reservoirs of infection, monitoring imported malaria and its contribution to local transmission, characterizing the origins and dynamics of malaria outbreaks, and estimating the frequency of Plasmodium vivax relapses. However, the priority of each use case varies with different endemic settings. Although a one-size-fits-all approach to molecular surveillance is unlikely to be applicable across the Asia-Pacific region, consensus on the spectrum of added-value activities will help support data sharing across national boundaries. Knowledge exchange is needed to establish local expertise in different laboratory-based methodologies and bioinformatics processes. Collaborative research involving local and international teams will help maximize the impact of analytical outputs on the operational needs of NMCPs. Research is also needed to explore the cost-effectiveness of genetic epidemiology for different use cases to help to leverage funding for wide-scale implementation. Engagement between NMCPs and local researchers will be critical throughout this process.
亚太地区在实现 2030 年消除疟疾目标方面面临着严峻的挑战。疟原虫的分子监测可以提供有关疟疾传播和适应的重要信息,从而为国家疟疾控制规划(NMCP)的决策过程提供信息。2019 年 11 月,在印度尼西亚雅加达举行了寄生虫基因分型研讨会,以审查寄生虫监测的分子方法,并探讨如何将这些工具纳入公共卫生系统并为政策提供信息。来自 8 个疟疾流行国家和亚太疟疾消除网络合作伙伴的 70 名参与者参加了会议。与会者承认寄生虫基因分型的多种用途,包括:量化耐药寄生虫的流行率、预测治疗失败的风险、确定主要的感染途径和储存库、监测输入性疟疾及其对当地传播的贡献、描述疟疾暴发的起源和动态、估计间日疟原虫复发的频率。然而,每个用例的优先级因不同的流行情况而异。虽然一刀切的分子监测方法不太可能适用于整个亚太地区,但对增值活动范围的共识将有助于支持跨国界的数据共享。需要进行知识交流,以在不同的实验室方法和生物信息学流程中建立本地专业知识。涉及当地和国际团队的合作研究将有助于最大限度地提高分析结果对 NMCP 运营需求的影响。还需要研究遗传流行病学在不同用例中的成本效益,以帮助为广泛实施筹集资金。NMCP 与当地研究人员之间的互动在整个过程中至关重要。